Cryopreservation moderates the thrombogenicity of arterial allografts during storage.
<h4>Introduction</h4>Management of vascular infections represents a major challenge in vascular surgery. The use of cryopreserved vascular allografts could be a feasible therapeutic option, but the optimal conditions for their production and use are not precisely defined.<h4>Aims&l...
Guardado en:
Autores principales: | , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9353e369935f4b2c933d3d62da22a259 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:9353e369935f4b2c933d3d62da22a259 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:9353e369935f4b2c933d3d62da22a2592021-12-02T20:04:56ZCryopreservation moderates the thrombogenicity of arterial allografts during storage.1932-620310.1371/journal.pone.0255114https://doaj.org/article/9353e369935f4b2c933d3d62da22a2592021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0255114https://doaj.org/toc/1932-6203<h4>Introduction</h4>Management of vascular infections represents a major challenge in vascular surgery. The use of cryopreserved vascular allografts could be a feasible therapeutic option, but the optimal conditions for their production and use are not precisely defined.<h4>Aims</h4>To evaluate the effects of cryopreservation and the duration of storage on the thrombogenicity of femoral artery allografts.<h4>Methods</h4>In our prospective study, eleven multi-organ-donation-harvested human femoral arteries were examined at five time points during storage at -80°C: before cryopreservation as a fresh native sample and immediately, one, twelve and twenty-four weeks after the cryopreservation. Cross-sections of allografts were perfused with heparin-anticoagulated blood at shear-rates relevant to medium-sized arteries. The deposited platelets and fibrin were immunostained. The thrombogenicity of the intima, media and adventitia layers of the artery grafts was assessed quantitatively from the relative area covered by fibrin- and platelet-related fluorescent signal in the confocal micrographs.<h4>Results</h4>Regression analysis of the fibrin and platelet coverage in the course of the 24-week storage excluded the possibility for increase in the graft thrombogenicity in the course of time and supported the hypothesis for a descending trend in fibrin generation and platelet deposition on the arterial wall. The fibrin deposition in the cryopreserved samples did not exceed the level detected in any of the three layers of the native graft. However, an early (up to week 12) shift above the native sample level was observed in the platelet adhesion to the media.<h4>Conclusions</h4>The hemostatic potential of cryopreserved arterial allografts was retained, whereas their thrombogenic potential declined during the 6-month storage. The only transient prothrombotic change was observed in the media layer, where the platelet deposition exceeded that of the fresh native grafts in the initial twelve weeks after cryopreservation, suggesting a potential clinical benefit from antiplatelet therapy in this time-window.László HidiErzsébet KomorowiczGergely Imre KovácsZoltán SzeberinDávid GarbaiszNatalia NikolovaKiril TenekedjievLászló SzabóKrasimir KolevPéter SótonyiPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0255114 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q László Hidi Erzsébet Komorowicz Gergely Imre Kovács Zoltán Szeberin Dávid Garbaisz Natalia Nikolova Kiril Tenekedjiev László Szabó Krasimir Kolev Péter Sótonyi Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
description |
<h4>Introduction</h4>Management of vascular infections represents a major challenge in vascular surgery. The use of cryopreserved vascular allografts could be a feasible therapeutic option, but the optimal conditions for their production and use are not precisely defined.<h4>Aims</h4>To evaluate the effects of cryopreservation and the duration of storage on the thrombogenicity of femoral artery allografts.<h4>Methods</h4>In our prospective study, eleven multi-organ-donation-harvested human femoral arteries were examined at five time points during storage at -80°C: before cryopreservation as a fresh native sample and immediately, one, twelve and twenty-four weeks after the cryopreservation. Cross-sections of allografts were perfused with heparin-anticoagulated blood at shear-rates relevant to medium-sized arteries. The deposited platelets and fibrin were immunostained. The thrombogenicity of the intima, media and adventitia layers of the artery grafts was assessed quantitatively from the relative area covered by fibrin- and platelet-related fluorescent signal in the confocal micrographs.<h4>Results</h4>Regression analysis of the fibrin and platelet coverage in the course of the 24-week storage excluded the possibility for increase in the graft thrombogenicity in the course of time and supported the hypothesis for a descending trend in fibrin generation and platelet deposition on the arterial wall. The fibrin deposition in the cryopreserved samples did not exceed the level detected in any of the three layers of the native graft. However, an early (up to week 12) shift above the native sample level was observed in the platelet adhesion to the media.<h4>Conclusions</h4>The hemostatic potential of cryopreserved arterial allografts was retained, whereas their thrombogenic potential declined during the 6-month storage. The only transient prothrombotic change was observed in the media layer, where the platelet deposition exceeded that of the fresh native grafts in the initial twelve weeks after cryopreservation, suggesting a potential clinical benefit from antiplatelet therapy in this time-window. |
format |
article |
author |
László Hidi Erzsébet Komorowicz Gergely Imre Kovács Zoltán Szeberin Dávid Garbaisz Natalia Nikolova Kiril Tenekedjiev László Szabó Krasimir Kolev Péter Sótonyi |
author_facet |
László Hidi Erzsébet Komorowicz Gergely Imre Kovács Zoltán Szeberin Dávid Garbaisz Natalia Nikolova Kiril Tenekedjiev László Szabó Krasimir Kolev Péter Sótonyi |
author_sort |
László Hidi |
title |
Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
title_short |
Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
title_full |
Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
title_fullStr |
Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
title_full_unstemmed |
Cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
title_sort |
cryopreservation moderates the thrombogenicity of arterial allografts during storage. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2021 |
url |
https://doaj.org/article/9353e369935f4b2c933d3d62da22a259 |
work_keys_str_mv |
AT laszlohidi cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT erzsebetkomorowicz cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT gergelyimrekovacs cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT zoltanszeberin cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT davidgarbaisz cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT natalianikolova cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT kiriltenekedjiev cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT laszloszabo cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT krasimirkolev cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage AT petersotonyi cryopreservationmoderatesthethrombogenicityofarterialallograftsduringstorage |
_version_ |
1718375556893900800 |